Cartilage formation in the chick limb follows rapid proliferation, condensation and differentiation of limb mesenchyme. The control of these early events is poorly understood. Platelet-derived growth factor receptor alpha (PDGFR-a ) is present throughout the mesenchyme of early chick limb buds, while its ligand, PDGF-A, is expressed in the surrounding epithelium. PDGFR-a is down-regulated in areas that will not give rise to cartilage and is then lost from cartilage forming areas after they begin to differentiate. PDGF-A increases chondrogenesis in micromass cultures of stage-20±24 limb buds, but not stage 25, where it inhibits chondrogenesis. Ectopic PDGF-A in the chick wing can lead to either a localized increase in cartilage formation, or an inhibition. Inhibition of PDGF signalling in the chick limb results in the loss of cartilage. These data demonstrate that PDGF-A functions to promote chondrogenesis at early stages of limb development and suggest that it inhibits chondrogenesis at later stages. q
Introduction
The vertebrate limb bud consists initially of a mass of undifferentiated mesenchyme bound by an epithelium. The ®rst overt stage in the formation of cartilage from this mesenchyme is the condensation of cells at the core of the limb bud. Only after cells have reached suf®cient density do they begin to differentiate into cartilage (Fell and Canti, 1934; Aulthouse and Solursh, 1987; Kulyk et al., 1989) . After subsequent growth and elaboration of these cartilage elements, further differentiation is initiated that leads eventually to the formation of bone. The latter stages of this process are beginning to be understood and involve signalling molecules such as ®broblast growth factors, Indian hedgehog and members of the bone morphogenetic protein (BMP) family (Macias et al., 1997; Merino et al., 1998; Pathi et al., 1999; Sahni et al., 1999; St-Jacques et al., 1999) . However, it is not known how the initial steps of mesenchymal proliferation and condensation are controlled.
It has been shown previously that platelet-derived growth factor receptor alpha (PDGFR-a ) is present throughout the mesenchyme of the early mouse limb. At later stages PDGFR-a is present in the condensing chondrogenic mesenchyme, then the perichondrium. In contrast, its ligand, PDGF-A, is present in the epithelium surrounding the limb bud and is also expressed in the limb musculature . These data suggest that PDGF-A may play a role in cartilage development.
The potential role for PDGF-A during cartilage development has not been made apparent by genetic mutations in the mouse. Neither the naturally occurring Patch mutant, which lacks PDGFR-a (Smith et al., 1991; Stephenson et al., 1991) , nor a targeted null of this allele (Soriano, 1997) display any obvious defects in limb skeletogenesis, except for a minor defect in the scapula of PDGFR-a knockout mice. These animals exhibit severe defects in derivatives of the cranial neural crest and die in utero (MorrisonGraham et al., 1992; Schatteman et al., 1992; Soriano, 1997) . Similarly, a targeted mutation of the PDGF-A allele does not affect limb development (Bostro Èm et al., 1996) . Unlike mice lacking PDGFR-a , PDGF-A null animals survive until birth and display defects primarily in lung development. Taken together these data show that neither PDGFR-a nor PDGF-A are essential for the development of the mouse limb. However, it is possible that their functions are redundant and replaced by other members of the PDGF family, or by other signalling molecules. Furthermore, the embryonic or perinatal death of these animals may not reveal the full extent of defects in the limb.
PDGF can induce chondrocyte proliferation and cartilage formation in cultures from post-natal rats (Kieswetter et al., 1997) and is associated with bone formation in fracture models (Andrew et al., 1995) . PDGF-AA also causes the proliferation of embryonic limb bud mesoderm in micromass cultures from stage-24 and -25 chick limb buds, while at the same time cartilage formation is inhibited (Chen et al., 1992; Potts and Carrington, 1993; Carrington and Eierle, 1995) . How might these differing actions of PDGF-A on chondrogenesis be reconciled? In this study, the detailed expression patterns of PDGF-A and PDGFRa transcripts in the chick limb are described. The presence of PDGFR-a mRNA throughout the early limb bud mesenchyme is compatible with a role in proliferation of this tissue. The restriction of the receptor to perichondrial regions at later stages coupled with the expression of PDGF-A in adjacent muscle suggests a role in limiting the extent of cartilage formation. Consistent with these observations, PDGF-AA increases cartilage formation in micromass cultures of chick limb buds from stages 20±24, but by stage 25, chondrogenesis is unaffected or slightly inhibited. Similarly, grafts that introduce ectopic PDGF-A into the chick limb lead to local increases, decreases or deformations of cartilage elements, depending on the site and type of graft. In addition, inhibition of PDGF signalling in the limb leads to the loss of distal and posterior cartilaginous elements. These experiments point to a complex and stagedependent role of PDGF-A on cartilage development in the chick limb.
Results

PDGF-A and PDGFR-a mRNA expression in the chick limb
The distribution of PDGF-A and PDGFR-a mRNA transcripts in the developing chick limb were examined using whole-mount in situ hybridization. PDGF-A mRNA is expressed uniformly throughout the ectoderm covering the lateral mesoderm at stage 15 and is expressed at slightly higher levels towards the edges of the lateral body folds (Fig. 1A) . In addition, PDGF-A mRNA is present in the ectoderm extending towards the paraxial mesoderm and overlying the condensing mesoderm of the presumptive limb buds. At stage 16, PDGF-A expression is most concentrated in the ectoderm overlying the developing limb buds and the level of expression in the interlimb region of thē ank is reduced (Fig. 1B) . PDGF-A expression is maintained in the limb ectoderm as the limb buds begin to grow, and in addition, is expressed in both the dorsal and ventral muscle masses as these begin to differentiate (Fig. 1C±F) . As chondrogenesis proceeds in the limb, PDGF-A expression becomes restricted distally to the ectoderm overlying the interdigital mesenchyme and continues to be expressed strongly in the deep and super®cial dorsal and ventral muscle masses, as well as the short toe muscle masses in the leg (Fig. 1G±I) .
PDGFR-a mRNA is expressed in a complementary pattern to PDGF-A in the chick limb, as has been described for a number of other species and tissues (reviewed in Ataliotis and Mercola, 1997) . At stage 16, PDGFR-a is present at low levels in the lateral mesoderm ( Fig. 2A) . Levels of PDGFR-a mRNA increase in the region of the presumptive limbs (Fig. 2B,C) and by the time the limb buds have begun to grow out, PDGFR-a is expressed uniformly and at high levels throughout the limb mesenchyme, except for the most distal part of the limb (Fig. 2D±G) . As chondrogenesis begins, PDGFR-a expression is reduced in areas where cartilage precursors have begun to condense. Mesenchyme condensation and differentiation into cartilage begins at stage 24 in the proximal core of the chick limb (Fell and Canti, 1934; Dessau et al., 1980) . By stage 26, the proximal core of the limb bud displays reduced levels of PDGFR-a expression (Fig. 2H) . At later stages, the forming digits and long bones are apparent by the absence of PDGFR-a mRNA, which is restricted to the interdigital mesenchyme and the perichondrial regions of the limb mesenchyme (Fig. 2I,J) .
PDGF-AA increases cartilage formation in early limb bud micromass cultures
It has been shown previously that PDGF-A inhibits chondrogenesis in micromass cultures of limb bud mesoderm made at stage 24 (Chen et al., 1992) . This result appears consistent with the later expression patterns of PDGF-A and its receptor in the chick limb, where PDGFR-a expression is rapidly lost from chondrogenic regions after cartilage has begun to form (Figs. 1F±I and 2H±J) . However, PDGFR-a is present throughout the limb bud mesenchyme at earlier stages, which is not consistent with a simple inhibition of chondrogenesis. To investigate this problem further, the effect of PDGF-AA on micromass cultures at various stages was examined. Micromass cultures were stained with alcian blue to detect Type II collagen, a marker of cartilage formation.
In stage-21 micromass cultures, addition of 50 ng/ml PDGF-AA causes an increase in the number and size of cartilage nodules stained with alcian blue (Fig. 3A,B) . This PDGF-AA-dependent increase in cartilage formation also occurs in stage-24 cultures (Fig. 3C,D) . The PDGF-AA-dependent increase in chondrogenesis is dose-dependent and spectrophotometric measurement of extractable alcian blue staining shows a linear increase between 12.5 and 50 ng/ml PDGF-AA, the highest dose tested (Fig. 3E) . At all stages between 20 and 24, addition of 50 ng/ml PDGF-AA causes an increase in the amount of chondrogen-esis in micromass cultures (Fig. 3F ) although the greatest relative increase is observed at stages 20 and 21 and the smallest increase at stage 24. At stage 25 there is a slight reduction in chondrogenesis upon addition of PDGF-AA as judged by alcian blue staining, but this is not statistically different to controls (Fig. 3F) . However, cartilage nodules tend to look smaller and are fewer in number (Fig. 3G,H ).
DNA synthesis and apoptosis in micromass cultures
Chondrogenesis in micromass cultures is dependent on cells reaching a critical density. Two possible ways that PDGF-AA might increase cell density in early micromass cultures are to promote cell division and/or to prevent apoptosis. Conversely, PDGF-AA might inhibit cell division or promote apoptosis in stage-25 cultures, where its effect on chondrogenesis is inhibitory.
DNA synthesis was compared in micromass cultures made from either stage-20 or -25 limb buds by measuring (Fig. 4) . In parallel cultures grown in 0.5% serum, there is no evidence of apoptosis after 16 h, as judged by activation of caspase 3. The presence of PDGF-AA in these cultures has no discernible effect on caspase 3 activation (Table 1) .
Ectopic PDGF-AA in the limb
Since PDGF-AA can increase chondrogenesis in cultures of limb bud mesoderm, its effect on cartilage formation in the embryo was also assessed. Ectopic PDGF-AA was delivered to chick limb buds using controlled pore glass beads soaked in 0.5 mg/ml of recombinant human PDGF-AA. Glass beads were grafted into the distal part of the limb bud, just below the apical ectodermal ridge of embryos between stages 21 and 23. Embryos were incubated until they had reached stages 35±36, then stained with alcian blue/alizarin red to reveal cartilaginous and ossifying skeletal elements.
Ectopic PDGF-AA introduced on glass beads causes two distinct phenotypes in the digits of the chick limb bud. First, there is overproduction of cartilage leading to an expansion of this tissue in the direction of the anterior-posterior axis of the limb. Second, there is a shortening of skeletal elements in the autopod along the proximal±distal axis and in particular, truncation of the distal phalanges. Truncation of distal elements occurs to some extent in all affected limbs, while expansion of cartilage occurs in only a proportion of affected embryos. The range of defects observed are a combination of these two phenotypes and are also affected by the position of the graft.
Fig . 5A ,B shows the result of a graft into a stage-22 embryo, slightly posterior to the apex of the wing bud in the region that is fated to give rise to either the anterior part of digit 4 or the posterior part of digit 3 ). An additional digit-like structure has formed between digits 3 and 4 which has begun to ossify at its proximal tip, in a location corresponding to ossi®cation centres in the adjacent digits. It is not possible to assign an identity to this extra digit, but it seems highly unlikely that it has arisen as a result of pattern duplication. The humerus, radius and ulna of the grafted limb appear normal, as does digit 4, but digits 2 and 3 are truncated and missing distal phalanges. It is unclear whether the terminal phalanges have fused with their more proximal neighbours, or whether their outgrowth has been perturbed. This truncation is present to some extent in all embryos affected by ectopic PDGF-AA.
The extent of extra cartilage formation can vary from a slight enlargement immediately surrounding the implanted glass bead (Fig. 5C,D) , to a more extensive overgrowth that involves all the skeletal elements of the autopod (Fig. 5E,F) . In some instances, there is no apparent increase in cartilage formation, but deformation and/or truncation of individual digits occurs (Fig. 5G±J ). Such defects in speci®c digits correspond to the position of the graft along the anterior± posterior axis. Thus, apical and slightly anterior grafts tend to produce defects in digit 2, while more posterior grafts affect digit 3. Defects in digit 4 alone have not been observed, but grafts of glass beads were not made into the polarizing region of the limb bud.
The incidence of defects produced by delivering ectopic PDGF-AA with glass beads is quite low (eight out of 47 grafts). However, these defects are never seen in control embryos (n 27). As a further control for the speci®city of PDGF action, alternative methods have been used to deliver this growth factor to the limb bud. Similar effects are also seen when ectopic PDGF is supplied by grafting cell pellets of chick embryo ®broblasts (CEFs) infected with the retrovirus RCASBP-A carrying the mouse PDGF-A gene. Fig. 6A shows the fused carpal and metacarpal elements of a wing bud following a graft into the posterior region of a stage-20 embryo. As with grafts of glass beads, the distal phalanges are truncated. Control grafts using uninfected CEFs never gave rise to defects in the embryo. When recombinant human PDGF-AA is applied using af®gel blue beads, limb defects are present in the proximal region of the wing, so that the humerus is affected but not the radius, ulna or the digits. As with the other types of graft, the position of the defect is in the vicinity of the bead. In this case, the beads are easily visible after grafting and their presence and position can often be monitored over the ®rst 24±48 h in ovo. Beads that have been grafted into the posterior region of the limb bud at stages between 20 and 22 are most often present proximally along the posterior edge of the limb bud 24 h later. The humerus appears shorter than on the unoperated side or compared to control embryos and is also greatly thickened (Fig. 6B,C) . In addition, the humerus cartilage curves dramatically away from the grafted bead, so that there is a clear region where no cartilage had formed immediately adjacent to the bead (Fig. 6C) . Control grafts using beads soaked in either 1% bovine serum albumin or 0.1 M acetic acid never gave rise to defects in the developing limb.
Inhibition of PDGF-signalling in the limb
Application of ectopic PDGF-AA to chick limb buds is suf®cient to produce defects in cartilage elements. How might the attenuation of PDGF-signalling in the chick limb affect chondrogenesis? This question has been addressed using a dominant negative mutant of PDGFR-a . A truncated version of human PDGFR-a , D798, was inserted into RCASBP-B. This retrovirus was multiply injected into the prospective right leg ®eld of stage-9±11 chick embryos, which were then grown on until stages 35±36. Skeletons were analysed following alcian blue/alizarin red staining. Chondrogenic defects were apparent in 29% of embryos (n 41). These defects are unilateral and limited to the infected side of the embryo, primarily to the distal and posterior regions of the limb. In all cases there is a reduction in the length and/or width of the ®bula, tibia and digits (particularly the metatarsals), though in the majority (83%) of cases this is subtle (Fig. 7A) . The most severely affected embryos lack the ®bula completely, and all or part of digit 4 (Fig. 7B) . Although greatly reduced in size, the correct number of phalanges seem to be present in the remaining digits. Such defects are never observed in control embryos, nor the contralateral, uninfected limb, demonstrating that PDGF-signalling is essential for at least some aspects of chondrogenesis in the chick limb.
Discussion
The limb is one of the most prominent sites of PDGF-A and PDGFR-a expression in the chick embryo. PDGF-A mRNA is present throughout the ectoderm overlying the paraxial and lateral mesoderm before the limb buds appear, and rapidly becomes more pronounced in the ectoderm overlying the emerging limb buds compared to the intervening¯ank region. As muscle appears in the limb buds, this too expresses PDGF-A and this pattern of ectodermal and muscle expression continues late into limb development. At the same time, PDGFR-a expression in the lateral mesoderm of the developing limb buds increases dramatically and remains at high levels throughout the limb bud mesenchyme until shortly after chondrogenesis begins at about stages 24±25 (Fell and Canti, 1934; Dessau et al., 1980; Carrington and Eierle, 1995) . PDGFR-a mRNA is then lost from regions undergoing chondrogenesis, so that PDGFR-a expression outlines the forming digits and long bones of the limbs. The pattern of expression for receptor and ligand in the chick limb is very similar to that described for the mouse embryo (Orr-Urtreger and Lonai, 1992; OrrUrtreger et al., 1992) except that neither PDGF-A nor PDGFR-a in the chick are present in the apical ectodermal ridge (Figs. 1E and 2F ). These ®ndings appear to represent a species speci®c difference. A previous report of PDGFR-a expression in chick limb bud ectoderm (Potts and Carrington, 1993 ) is most likely to be due to the use of reverse transcriptase±polymerase chain reaction (RT±PCR) in this study, which may have detected PDGFR-a mRNA from small amounts of contaminating mesoderm cells present in dissected tissues.
The pattern of expression of these two genes strongly suggests signalling to the limb mesenchyme from the overlying ectoderm beginning at the earliest stages of limb mesoderm condensation and continuing throughout limb bud outgrowth. Additionally, the limb musculature acts as a further source of PDGF-A which presumably signals to the adjacent non-muscle mesenchyme. It is possible that PDGF-A acts initially to promote the rapid outgrowth of the limb bud, since it is a potent mitogen of mesenchymal cells (reviewed in Ross et al., 1986) . Furthermore, PDGF-AA has been shown previously to stimulate DNA synthesis in micromass cultures of chick limb buds (Chen et al., 1992; Potts and Carrington, 1993; Carrington and Eierle, 1995) .
In this study, PDGF-AA was found to increase chondrogenesis in micromass cultures made from limb buds between stages 20 and 24. The effect of PDGF-AA was most marked in younger cultures and decreased with successive stages. Since chondrogenesis is established only after cells have accumulated to a critical density (Fell and Canti, 1934; Kulyk et al., 1989) , PDGF-AA may increase cartilage formation in micromass cultures simply by promoting cell division, or survival. In support of the latter hypothesis, PDGF-AA stimulates DNA synthesis in micromass cultures from both stage-20 and -25 embryonic limb buds. At the same time, apoptosis in micromass cultures, as judged by caspase 3 activation, remains below the level of detection in the presence or absence of PDGF-AA. The decline in the ability of 50 ng/ml PDGF-AA to stimulate cartilage formation with age does not represent a loss in chondrogenic potential of the tissue. Evidence for this comes from the observation that, at all stages examined, growth of cultures in either 10% calf serum or the presence of 5 mg/ml insulin always causes more cartilage to differentiate than PDGF-AA alone (data not shown). Furthermore, at stage 25, PDGF-AA has an inhibitory effect on cartilage formation as judged by the size and appearance of cartilage nodules, although the decrease in extractable alcian blue staining is less apparent. These data are consistent with an instructive role for PDGF in inhibiting cartilage differentiation rather than a loss of responsiveness in this tissue as it matures, since cultures show increased DNA synthesis in response to PDGF-AA. These data also concur with a previous report that PDGF-AA can inhibit chondrogenesis in stage-24 chick limb bud cultures (Chen et al., 1992) . A slight discrepancy with the results presented here (inhibition at stage 25 vs. stage 24) may re¯ect differences in staging of embryos, culture conditions and the method of assay for cartilage. These in vitro ®ndings are consistent with the later stages of PDGFR-a expression in perichondrial regions and its down-regulation in cartilage at more advanced stages of differentiation. It is perhaps a consequence of this differentiation which leads to the loss of PDGFR-a expression, as is thought to happen when oligodendrocyte progenitors differentiate (Hart et al., 1989) . When ectopic PDGF-A is applied to the limb bud, its effects are twofold. First, there is a localized increase in the amount of cartilage that forms adjacent to the graft site that can lead to additional cartilage elements, expansion of existing cartilage or fusion of the cartilages of the digits. Second, there is an inhibition of cartilage formation that often results in a shortening of the affected elements along the proximal-distal axis, or a deformation of the cartilage away from the source of ectopic PDGF. These events can occur either alone or together and both affect the morphology rather than the patterning of the limb. In the most extreme case seen, an additional digit-like cartilage was formed, which may be the result of an expansion of the chondrogenic mesenchyme, thus providing suf®cient cell mass for this extra element. The variations in limb phenotype observed may be caused by the precise timing and location of the graft. There is certainly a correlation between the positioning of the graft along the anterior-posterior axis and the affected digit(s). However, no obvious correlation exists between the stage of the grafted embryo (between stages 20 and 22) and whether the effect on cartilage is predominantly inhibitory or stimulatory. The ability to induce defects in the limb bud with ectopic PDGF-A may be reduced further by the already high level of expression of this gene, and the regional downregulation of PDGFR-a as cartilage condensations begin to form. Thus, ectopic PDGF-A needs to be delivered at suf®-ciently high levels and to areas of the limb bud that are still expressing PDGFR-a . Most of the limb mesenchyme expresses PDGFR-a in the early limb bud, although not all this mesenchyme is fated to form cartilage . Therefore, not all PDGFR-a -expressing cells will give rise to cartilage in vivo. It seems likely that other factors control the down-regulation of PDGFR-a and thus limit the region of the limb that can be perturbed by additional PDGF-A.
Variation in phenotype in vivo is also brought about by the type of graft used. Controlled-pore glass beads and cell aggregates tend to remain at distal locations in the limb, when grafted under a loop of the apical ridge. Accordingly, the digits are most commonly affected following such grafts. Expansion of cartilage along the anterior-posterior axis of the digital plate is often coupled with fusion of adjacent elements and a reduction in length along the proximal±distal axis. Also, the most distal phalanges are either lost, or fused with their more proximal neighbours. In contrast, Af®gel-blue beads are found in proximal locations and predominantly affect the humerus, which appears shorter and thicker. Cartilage formation immediately adjacent to the grafted bead is inhibited and the humerus often curves away at this point. The differences seen between grafts that affect proximal regions and those that affect distal regions can most easily be explained by the normal temporal progression of chondrogenesis from the humerus towards the digits (reviewed in Tickle and Eichele, 1994) . Thus, grafts placed at the distal tip of the limb bud that acquire different relative positions along the emerging bud will come to lie next to cartilage at slightly different stages of differentiation. Therefore, the observed effects of PDGF both in vivo and in vitro can be reconciled. Proximal grafts are in contact with more mature mesenchyme, similar to stage-25 micromass cultures and are more likely to have inhibitory effects. Distal grafts are in contact with young mesenchyme when grafted and can promote chondrogenesis, but as the embryo develops, the effect will become progressively inhibitory. It remains unclear how these differential effects of PDGF with time are achieved and whether it is the same mesenchymal cells changing their response to PDGF, or a different population of emerging PDGFR-a-expressing cells.
The addition of PDGF-A can clearly affect chondrogenesis in culture and in the chick embryo, while the absence of either PDGF-A or PDGFR-a in the mouse embryo does not have any apparent effect on limb development Bostro Èm et al., 1996; Soriano, 1997) . It is possible that PDGF signalling plays no role during chondrogenesis in limb development, or that redundant systems exist to ensure that this crucial process is properly controlled. The latter possibility is supported by in vitro data showing that BMP-2 can promote chondrogenesis (Duprez et al., 1996) , even under conditions where PDGF is inhibitory (Chen et al., 1992) . Also, insulin and insulin-like growth factor I can inhibit the mitogenic activity of PDGF-AA in micromass cultures (Carrington and Eierle, 1995) and FGF signalling inhibits chondrocyte proliferation (Sahni et al., 1999) . In contrast to loss of function studies in the mouse, inhibition of PDGF signalling in the chick embryo using a dominant negative PDGFR-a mutant (D798) is able to perturb chondrogenesis in the limb. This is manifested by a reduction in the size of distal skeletal elements, and in extreme cases results in the loss of individual bones. Thus, loss of PDGF signalling has the opposite effect to the application of additional PDGF. This difference between mouse and chick embryos may be species speci®c. Alternatively, it may be due to the use of a dominant negative inhibitor here, which is able to perturb signalling from both PDGFR-a and -b . PDGFR-b has been shown previously to be present throughout the early limb mesenchyme in mouse embryos (Shinbrot et al., 1994) . It is not clear if PDGFR-b is present in the chick limb at similar stages. However, previous attempts to detect PDGFR-b mRNA in the chick at early limb bud stages have failed (Potts and Carrington, 1993 ; unpublished data) even though PDGFRb can be detected by RT±PCR in stage-27 embryos (data not shown).
Why is only part of the limb affected in chick embryos infected with the D798 mutant? More speci®cally, why are distal and posterior regions most affected? Injection of retrovirus into the prospective limb ®eld at stage 10 results in complete infection of the limb by stage 21 (Morgan and Fekete, 1996) . It may be that there is insuf®cient time for the injected retrovirus to spread before PDGF-critical events have occurred. Consistent with this possibility is the ®nding that injection of D798 after stage 14 does not result in limb defects (data not shown). Alternatively, inhibition of PDGF signalling by the truncated receptor may be incomplete. While these possibilities cannot yet be distinguished, the likely outcome of attenuating the PDGF signal is to reduce the number of chondrocyte precursors in the limb bud. This could account for the reduction in the size of cartilaginous elements in the chick leg. Furthermore, since chondrogenesis requires a critical mass of cells to proceed, reduction below a threshold number of cells might account for the absence of the ®bula and digit 4 in some embryos. Previous work has shown that blocking limb mesenchyme division with colchicine or X-irradiation differentially affects speci-®c parts of the limb (Goff, 1962; Alberch and Gale, 1983) . In the chick leg, distal elements are most sensitive to this reduction in cell number (Goff, 1962) . It is interesting to note that cartilage differentiation in the chick limb proceeds in a proximal±distal and anterior±posterior direction. If the accumulation of D798 protein to inhibitory levels lagged behind the initial phases of chondrocyte differentiation, this could further account for the distal-posterior bias in the observed limb defects.
Taken together, the above experiments demonstrate that PDGF is suf®cient to increase chondrogenesis both in vitro and in vivo and promotes cell division in limb mesenchyme cultures. Furthermore, PDGF signalling is necessary for the formation of cartilage in the chick limb in vivo. It seems likely, therefore, that PDGF signalling is required for the early proliferation of chondrocyte precursors in the chick limb.
Experimental procedures
4.1. cDNA cloning cDNAs encoding full-length chicken PDGF-A and PDGFR-a were isolated from an HH10 embryonic cDNA library (Nieto et al., 1994) . PDGF-A clones were identi®ed using a low stringency screen with a mouse PDGF-A probe (Mercola et al., 1990) . PDGFR-a clones were identi®ed using an RT±PCR-derived chicken cDNA probe, isolated from stage-20 chick embryo RNA using degenerate oligonucleotide primers. Upstream primer 5
H -CCGAATTCCCA-GAGAARCCRAAGAARGA-3 H ; downstream primer 5 H -GGGAATTCTCNACMATCATGCCRGGRTA-3
H . cDNA clones of 1.4 and 6.5 kb were isolated that spanned the entire open reading frames of PDGF-A and PDGFR-a , respectively. The identity of these cDNA clones was con®rmed by sequencing and searching using the BLAST program at the NCBI. Sequences for chicken PDGF-A (AF188841) and PDGFR-a (AF188842) have been deposited in GenBank.
In situ hybridization
Whole-mount in situ hybridization was carried out according to standard procedures (Nieto et al., 1996) using either digoxygenin-11-UTP-or¯uorescein-12-UTP-labelled antisense cRNA probes for PDGF-A and PDGFR-a. Control sense probes did not give any detectable signal.
Virus construction
The mouse PDGF-A coding sequence was ampli®ed by PCR using 21-mer oligos corresponding to the 5 H and 3
H
ends of the open reading frame (Mercola et al., 1990 ). This PCR product was cloned into the EcoRI site of pCRII using a TA cloning kit (Invitrogen), then subcloned as an EcoRI fragment into the adapter plasmid SLAX-13. Clones in the sense orientation were identi®ed by restriction mapping and ligated as ClaI fragments into the ClaI site of RCASBP-A (Petropoulos and Hughes, 1991) . Sense clones were again identi®ed by restriction mapping and used to generate viral stocks. Concentrated viral stocks were prepared by centrifugation of supernatant from transfected chick embryo ®broblasts (CEFs) using standard methods (Morgan and Fekete, 1996) . Human PDGFR-a was altered by PCR mutagenesis to introduce a stop codon at position 2395±7 in the coding sequence. This is predicted to produce a truncated protein (HaRD798) similar to a known dominant negative inhibitor of PDGFR-a (Ueno et al., 1993) . This cDNA was subcloned as an NcoI/HindIII fragment into SLAX-13, then into the ClaI site of RCASBP-B. Sense clones were identi®ed by restriction mapping, then virus produced and concentrated as described above.
Bead and cell aggregate grafts
Fertile White Leghorn eggs were incubated at 388C until they had reached the appropriate stage (according to Hamburger and Hamilton, 1951) . Grafts were made into the right wing bud of embryos, either into the mesenchyme, or just beneath the apical ectodermal ridge. Cell aggregates of mPDGF-A RCASBP-A infected CEFs were made by plating approximately 5 £ 10 6 cells from a sub-con¯uent dish onto a 35-mm bacterial dish. After overnight incubation, the cells typically formed tight, spherical aggregates of approximately 200 mm in size. Cell pellets were washed three times in DMEM prior to grafting to remove PDGF and other growth factors which are present in the serum of the tissue culture medium.
Recombinant human PDGF-AA was applied to chick limb buds with either Af®gel-blue beads (Pharmacia), or on glass, controlled pore beads, mesh size 80±120 (Sigma). In both cases, beads were incubated in 2-ml droplets of 0.5 mg/ml PDGF-AA (Gibco-BRL or Immunokontact) in a humidi®ed dish at room temperature for at least 1 h prior to grafting. Af®gel blue beads were secured in place using platinum wire staples (Yang et al., 1997) , while glass beads were placed under a loop of apical ectodermal ridge or inserted deep into a slit in the limb mesenchyme.
Micromass cultures
Micromass cultures were prepared from chick wing buds at stages between 20 and 25 essentially as described (Swalla et al., 1983) . Brie¯y, limb buds were removed in phosphate buffered saline, then transferred to ice-cold 2.5% trypsin in Hank's buffered salt solution (Sigma) for 30±45 min, until the ectoderm had begun to detach. Limb buds were transferred to a solution of 1 mg/ml soybean trypsin inhibitor (Sigma) in serum-free DMEM/Ham's F12 (1:1) for 10 min, then the loose ectoderm was removed using sharpened tungsten needles. The limb mesenchyme was dissociated into a single cell suspension by trituration, cells were counted and washed twice in medium, then 10-ml droplets containing 2 £ 10 5 cells were plated into each well of a 24-well dish (Nunclon) in medium supplemented with 0.5% calf serum. Cultures were grown for 5 days in DMEM/ Ham's F12 (1:1) containing 0.5% newborn calf serum and supplemented with 50 ng/ml PDGF-AA where appropriate. Cartilage formation in micromass cultures was determined as described (Hassell and Horigan, 1982) by staining with a 1% solution of alcian blue in 3% acetic acid. Cultures were washed in 3% acetic acid, 1% HCl (pH 1), rinsed in 3% acetic acid (pH 2.5), then in distilled water. Cultures were photographed, then bound alcian blue was extracted in 6 M guanidinium hydrochloride overnight at 48C. The amount of extracted alcian blue was determined by reading the absorbance at 595 nm.
4.6. DNA synthesis assays DNA synthesis was determined by measurement of [ 3 H]thymidine incorporation. Micromass cultures were set up as before in 24-well plates and incubated in medium containing 0.5% calf serum and 0.4 mCi [ 3 H]thymidine per well, with or without 50 ng/ml PDGF-AA. After 16 h, cells were lysed in 1% SDS and DNA precipitated in 7.5% tricholoroacetic acid. The insoluble fraction was isolated on glass-®bre ®lters and the incorporated radioactivity measured by scintillation counting.
Apoptosis assays
Micromass cultures were set up as before, except that 3 micromasses were plated into each well of a 24-well plate. Cells were incubated for 16 h in medium containing 0.5% calf serum with or without 50 ng/ml PDGF-AA. Activated caspase 3 was used as an indicator of apoptosis in cultures. This activity was determined using a caspase 3 activity assay kit (Boehringer Mannheim) according to the manufacturer's instructions.
Histochemistry
Skeletal preparations of 10-day-old chick embryos were made by ®xation in 80% ethanol/20% acetic acid containing 15 mg/ml alcian blue, followed by dehydration in ethanol and staining with 50 mg/ml alizarin red S in 0.5% KOH. Tissue was cleared in a 4:1 mixture of 0.5% KOH and glycerol over 2±3 days, then transferred via a graded series of 0.5% KOH and glycerol over a period of several days through to 100% glycerol. Alternatively, embryos were ®xed in 5% trichloroacetic acid and stained with 0.5% alcian green, then dehydrated and cleared in 0.5% KOH as described above.
